A study of autoimmune related phenomena in 350 women with histologically confirmed lichen sclerosus et atrophicus revealed that 21.5% had one or more autoimmune related diseases, 21% had one or more first degree relatives with an autoimmune-related disease, 42% had an autoantibody at a titre greater than 1:20, and 59.5% had one or more of these autoimmune-related phenomena. No statistically significant differences in the natural history of lichen sclerosus et atrophicus were demonstrated between those patients with autoimmune-related phenomena and those without.
Summary
In 1969 an apparently unique patient with myasihenia gravis alopecia and an associated widespread hair follicle hamartoma was reported by Brown, Crounse & Winkelmann (1969). We describe here a case which shows striking clinical and pathological similarities 10 that original patient.
Patients and Methods201 women with anogenital dermatoses were referred to our contact dermatitis clinic over 14 years: Ill had a diagnosis of eczema, in 44 the diagnosis was unknown and in 46 the diagnosis was one of the following; psoriasis, lichen planus, vestibulitis or lichen sclerosus. 103 had a dermatosis only involving the vulva, 42 had perianal involvement only, and 56 had dermatoses involving both sites.They were tested against the European standard series, a medicament series, a corticosteroid series and their own topical medicaments. Other specific allergens were tested where relevant. Patches were removed and read at 2 days and again at 4 days.
An underlying skin disorder prior to the development of their carcinoma was found in 22 of 23 patients with vulval SCC and is therefore an important risk factor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.